Elevai Labs, Inc. Common Stock
Financial ratios & Valuation

Historical Multiples (2020 – 2023)

2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-13.46K-15.01K-3.59K-914.33N/A-9.30K
Price/Sales ratio
N/A14.24M8.45K2.29KN/A7.12M
Price/Book Value ratio
-127.25K26.15K5.72K1.02KN/A15.93K
Price/Cash Flow ratio
-13.82K-17.82K-4.08K-863.10N/A-10.95K
Price/Free Cash Flow ratio
-13.82K-16.99K-3.99K-860.99N/A-10.49K
Price/Earnings Growth ratio
N/A1.45K-11.26-8.27N/A723.53
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A-244.01%57.71%66.24%N/A-93.14%
Operating Profit Margin
N/A-94928.65%-233.37%-214.24%N/A-47581.01%
Pretax Profit Margin
N/A-94889.84%-234.93%-251.16%N/A-47562.38%
Net Profit Margin
N/A-94889.84%-234.93%-251.16%N/A-47562.38%
Effective Tax Rate
0.47%-0.00%0.00%N/AN/A-0.00%
Return on Assets
-1309.54%-117.78%-95.14%-82.88%N/A-106.46%
Return On Equity
944.97%-174.14%-159.13%-112.39%N/A-166.63%
Return on Capital Employed
940.45%-174.21%-137.14%-94.25%N/A-155.68%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A
Quick Ratio
0.412.062.133.40N/A2.10
Cash ratio
0.321.911.962.56N/A1.93
Days of Sales Outstanding
N/A754.716.127.70N/A380.41
Days of Inventory outstanding
N/A24.60K274.59312.99N/A12.43K
Operating Cycle
N/A25.35K280.71320.70N/A12.82K
Days of Payables Outstanding
N/A12.59K237.51376.44N/A6.41K
Cash Conversion Cycle
N/A12.76K43.19-55.74N/A6.40K
Debt Ratios
Debt Ratio
1.40N/AN/AN/AN/AN/A
Debt Equity Ratio
-1.01N/AN/AN/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
58.39N/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-9.04N/AN/AN/AN/AN/A
Company Equity Multiplier
-0.721.471.671.35N/A1.57
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-799.19-2.06-2.66N/A-400.63
Free Cash Flow / Operating Cash Flow Ratio
11.041.021.00N/A1.03
Cash Flow Coverage Ratio
-9.04N/AN/AN/AN/AN/A
Short Term Coverage Ratio
-9.04N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A